Quick answer
SVF (Stromal Vascular Fraction) is a mixed cell population freshly isolated from your own fat: roughly 30% adipose-derived stem cells, 25% immune cells, 20% fibroblasts, 15% pericytes and 10% endothelial progenitors. Cheongdam The Cell builds its stem cell recovery programmes on SVF because those five populations calm inflammation, repair tissue and restore microvasculature at the same time.
SVF is a cell team, not one cell type
Most people picture 'adipose stem cells' as one cell type, but what an SVF programme actually delivers is the cell community that lives around the capillaries of fat tissue. Cheongdam The Cell publishes the breakdown: about 30% adipose-derived stem cells (ASCs) doing the regeneration and differentiation, with the remainder acting as support cells that let repair proceed on several fronts at once.
Immune, vascular and fibroblast roles
The ~25% immune fraction modulates inflammation rather than amplifying it, while the ~10% endothelial progenitors and ~15% pericytes together build and stabilise new capillaries — a precondition for healing in poorly perfused tissue such as chronic wounds or thinning scalp. The ~20% fibroblast fraction produces the collagen that skin elasticity depends on.
The same-day autologous advantage
Practically, SVF is autologous — your own cells, so no immune rejection — and it is isolated the same day. There is no multi-week culture wait as with expanded MSCs, which is why many Cheongdam The Cell programmes can be completed in a single trip to Korea.
Limits to understand before deciding
It is equally important to be clear that SVF is not a guaranteed cure for any disease. Outcomes depend on general health, age, fat quality, comorbidities and the actual cell yield on the day. Physician assessment and a pre-injection cell count are core parts of the process, not fine print.
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.